Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: Effects of Glucagon Administration on Energy Expenditure [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the effect of glucagon administration on energy expenditure in participants with obesity and hyperglucagonemia; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLUCAGON (GLUCAGON)

Snippet

Sponsor: AdventHealth Translational Research Institute | Conditions: Hyperglucagonemia, Obesity | Phase 1 | Status: COMPLETED